Back to top
more

Align Technology (ALGN)

(Delayed Data from NSDQ)

$236.97 USD

236.97
597,597

-1.09 (-0.46%)

Updated Oct 3, 2024 03:59 PM ET

After-Market: $232.00 -4.97 (-2.10%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth A Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 29% (178 out of 252)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

Here's Why Align Technology (ALGN) is Poised for a Turnaround After Losing -10.74% in 4 Weeks

Align Technology (ALGN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Stryker (SYK) Gets FDA 501k Clearance for Pangea Trauma Systems

Stryker's (SYK) Pangea systems will boost the company's Trauma business unit following a complete launch. SYK plans to present the new system at the Annual Orthopaedic Trauma Association meeting.

DexCom (DXCM) Rises 7% in One Week: What's Driving It?

DexCom's (DXCM) shares have rallied nearly 7% over the past week, presumably on positive outlook for its CGM devices amid rising competition.

Reasons to Retain Baxter International (BAX) in Your Portfolio

Baxter International's (BAX) robust growth across all geographies, along with transformational initiatives, boosts confidence. However, pandemic-related disruption continues to hurt sales.

Align Technologies (ALGN) Brings New Upgrades for Oral Health

Align Technologies (ALGN) introduces a series of software innovations to accelerate the digital practice transformation.

Reasons to Retain Cardinal Health (CAH) in Your Portfolio

Cardinal Health (CAH) continues to gain traction from solid pharmaceutical segment and a diversified product portfolio. However, the rising cost of products is a concern.

Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now?

Smart Beta ETF report for RSPH

Here's Why You Should Retain Bruker (BRKR) Stock for Now

Investors continue to be optimistic about Bruker (BRKR), backed by the performance of the CALID and NANO groups and strength in acquisitions.

Align Technology's (ALGN) New Feature to Boost Patient Experience

Align Technology's (ALGN) introduction of the new SmartForce feature is expected to minimize the number of attachments while maintaining predictable treatment outcomes.

Align Technologies (ALGN) Set to Acquire Cubicure GmbH

Align Technologies (ALGN) announces acquisition of direct 3D printing pioneer Cubicure GmbH, backed by years of successful collaboration.

Merit Medical's (MMSI) Aspira Bottle to Boost At-Home Services

Merit Medical (MMSI) launches Aspira Bottle, complementing its Aspira Drainage System, that can provide compassionate home treatment option for critical cancer and other patients.

Henry Schein (HSIC) Down 1.5% Since Last Earnings Report: Can It Rebound?

Henry Schein (HSIC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Here's Why You Should Retain Omnicell (OMCL) Stock Now

Investors are optimistic about Omnicell (OMCL), owing to the strong prospect of the advanced services portfolio.

Why You Should Add Haemonetics (HAE) to Your Portfolio Now

Haemonetics' (HAE) share price is likely to grow, backed by solid business performance across all its segments.

Revvity (RVTY) Launches Three New Preclinical Research Systems

Revvity (RVTY) launches new preclinical imaging technologies for breakthrough discoveries. Learn how they can help advance research and boost Revvity's prospect.

DexCom's (DXCM) G6 CGM Connects With Omnipod 5 AID in Germany

DexCom's (DXCM) G6 CGM system and Omnipod 5 AID system can now simplify diabetes management and improve health outcomes in Germany.

NextGen's (NXGN) Shares Rise on Potential Acquisition Rumors

NextGen (NXGN) and a private equity firm, Thomas Bravo, are in advanced stages of discussion related to the acquisition of the former by the latter.

Reasons to Add Stryker (SYK) Stock to Your Portfolio Now

Stryker (SYK) continues to benefit from strength in the robotic arm-assisted surgery platform, Mako, and its broad product portfolio. However, pricing pressure weighs on the stock.

Veeva (VEEV) Rises on Robust Earnings: More Room to Grow?

Veeva (VEEV) reports better-than-expected earnings and revenues for the second quarter. The raised earnings outlook for fiscal 2024 reflects optimism. Will the uptrend in shares continue?

Cooper Companies (COO) Q3 Earnings In Line, '23 Outlook Raised

Cooper Companies' (COO) third-quarter fiscal 2023 revenues reflect a solid segmental performance with improved adjusted earnings amid rising expenses.

Patterson Companies (PDCO) Q1 Earnings In Line, Sales Hurt by FX

Patterson Companies' (PDCO) first-quarter fiscal 2024 results reflect robust improvement in Dental Equipment sales, value-added services and Animal Health segment.

Is Align Technology (ALGN) Stock Outpacing Its Medical Peers This Year?

Here is how Align Technology (ALGN) and Brainsway Ltd. Sponsored ADR (BWAY) have performed compared to their sector so far this year.

Align Technology (ALGN) Down 9% Since Last Earnings Report: Can It Rebound?

Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Earnings Estimates Rising for Align Technology (ALGN): Will It Gain?

Align Technology (ALGN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Align Technology (ALGN) Just Reclaimed the 50-Day Moving Average

When a stock breaks out above the 50-Day simple moving average, good things could be on the horizon. How should investors react?